119 related articles for article (PubMed ID: 35618211)
1. Cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer.
Cui J; Chen Y; Ou Y; Liu G; Wen Q; Zhu W; Liang L; Chen Z; Yang H; Wang L; Wei M
Clin Immunol; 2022 Jul; 240():109045. PubMed ID: 35618211
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
3. Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.
Nobeyama Y; Nakagawa H
J Dermatol Sci; 2016 Feb; 81(2):118-23. PubMed ID: 26642794
[TBL] [Abstract][Full Text] [Related]
4. Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway.
Qie Y; Zhou D; Wu Z; Liu S; Shen C; Hu H; Zhang C; Xu Y
Ecotoxicol Environ Saf; 2022 Aug; 241():113724. PubMed ID: 35660381
[TBL] [Abstract][Full Text] [Related]
5. GPRASP1 is a candidate anti-oncogene and correlates with immune microenvironment and immunotherapeutic efficiency in head and neck cancer.
Zhang T; Liu G; Zhang J; Chen S; Deng Z; Xie M
J Oral Pathol Med; 2023 Mar; 52(3):232-244. PubMed ID: 36264603
[TBL] [Abstract][Full Text] [Related]
6. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
7. AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma.
Conteduca G; Fenoglio D; Parodi A; Battaglia F; Kalli F; Negrini S; Tardito S; Ferrera F; Salis A; Millo E; Pasquale G; Barra G; Damonte G; Indiveri F; Ferrone S; Filaci G
Oncotarget; 2016 Sep; 7(38):60872-60884. PubMed ID: 27563821
[TBL] [Abstract][Full Text] [Related]
8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
9. Expression of the tumor-expressed protein MageB2 enhances rRNA transcription.
Ladelfa MF; Peche LY; Amato GE; Escalada MC; Zampieri S; Pascucci FA; Benevento AF; Do Porto DF; Dardis A; Schneider C; Monte M
Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119015. PubMed ID: 33741433
[TBL] [Abstract][Full Text] [Related]
10. Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress.
Peche LY; Ladelfa MF; Toledo MF; Mano M; Laiseca JE; Schneider C; Monte M
J Biol Chem; 2015 Dec; 290(49):29652-62. PubMed ID: 26468294
[TBL] [Abstract][Full Text] [Related]
11. Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment.
Huang J; Zhou L; Deng K
J Ovarian Res; 2023 Apr; 16(1):64. PubMed ID: 37005667
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.
Hikmet F; Rassy M; Backman M; Méar L; Mattsson JSM; Djureinovic D; Botling J; Brunnström H; Micke P; Lindskog C
Mol Oncol; 2023 Dec; 17(12):2603-2617. PubMed ID: 37341056
[TBL] [Abstract][Full Text] [Related]
13. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
Zeng H; Huang Y; Chen L; Li H; Ma X
Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
[TBL] [Abstract][Full Text] [Related]
14. MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.
Pattani KM; Soudry E; Glazer CA; Ochs MF; Wang H; Schussel J; Sun W; Hennessey P; Mydlarz W; Loyo M; Demokan S; Smith IM; Califano JA
PLoS One; 2012; 7(9):e45534. PubMed ID: 23029077
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor RUNX3 promotes CD8
Song Q; Shang J; Zhang C; Chen J; Zhang L; Wu X
J Cell Biochem; 2020 Jun; 121(5-6):3208-3220. PubMed ID: 31898342
[TBL] [Abstract][Full Text] [Related]
16. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
18. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu Z; You W; Qin J; Dai X; Shen H; Wang X; Wu J
Cell Prolif; 2019 May; 52(3):e12581. PubMed ID: 30895661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]